Your body needs time to break down and eliminate the destroyed fat cells through natural processes
25-39% The estimated proportion of weight lost on GLP-1 therapy that may come from lean mass rather than fat, based on body composition analyses from clinical trial data. The precise figure varies by patient, dose, and whether resistance exercise is incorporated
Researchers tracking how this evidence base matures can compare it with the companion assessment of whether current research supports cagrilintides role in lowering stroke risk, which weighs a similarly early evidence base for a different endpoint
Another known side effect of semaglutide is a direct change in your perception of flavors
Tirzepatide (Mounjaro) a dual GIP/GLP-1 receptor agonist licensed by the MHRA for type 2 diabetes
Hyperuricemia can downregulate the expression of cell cycle proteins including D1, p-Rb, Ki67, and CDK4, inducing cellular senescence and consequently diminishing EGF/EGFR signaling